Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$13.18 - $18.36 $239,586 - $333,748
-18,178 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$13.79 - $17.44 $34,254 - $43,320
2,484 Added 15.83%
18,178 $295,000
Q3 2019

Oct 24, 2019

BUY
$13.91 - $14.42 $5,828 - $6,041
419 Added 2.74%
15,694 $214,000
Q2 2019

Jul 24, 2019

SELL
N/A
-12,282 Reduced 44.57%
15,275 $209,000
Q1 2019

Apr 29, 2019

BUY
N/A
10,029 Added 57.22%
27,557 $407,000
Q4 2018

Jan 17, 2019

BUY
N/A
9,982 Added 132.28%
17,528 $211,000
Q3 2018

Oct 29, 2018

BUY
N/A
1,007 Added 15.4%
7,546 $119,000
Q2 2018

Aug 09, 2018

BUY
N/A
1,341 Added 25.8%
6,539 $91,000
Q1 2018

May 10, 2018

BUY
N/A
4,149 Added 395.52%
5,198 $74,000
Q4 2017

Jan 31, 2018

BUY
N/A
77 Added 7.92%
1,049 $9,000
Q3 2017

Oct 13, 2017

BUY
N/A
285 Added 41.48%
972 $9,000
Q2 2017

Aug 15, 2017

BUY
N/A
687
687 $2,000

Others Institutions Holding ALPMY

About Astellas Pharma Inc Unsponsore


  • Ticker ALPMY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,827,069,952
  • Market Cap $17.9B
More about ALPMY
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.